Antibiotic therapy and Clostridium difficile infection - primum non nocere - first do no harm

about

The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies.

P2860

Q37669836-373BFCD1-4371-46F2-BE12-EE6A4E04DDD0

P2860

Antibiotic therapy and Clostridium difficile infection - primum non nocere - first do no harm

Item

http://www.wikidata.org/entity/Q36078316

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Antibiotic therapy and Clostri ...... non nocere - first do no harm

@ast

Antibiotic therapy and Clostri ...... non nocere - first do no harm

@en

type

Item

label

Antibiotic therapy and Clostri ...... non nocere - first do no harm

@ast

Antibiotic therapy and Clostri ...... non nocere - first do no harm

@en

prefLabel

Antibiotic therapy and Clostri ...... non nocere - first do no harm

@ast

Antibiotic therapy and Clostri ...... non nocere - first do no harm

@en

P1154

2-s2.0-84941915127

http://www.w3.org/2001/XMLSchema#string

P1433

Infection and Drug Resistance

P1476

Antibiotic therapy and Clostri ...... non nocere - first do no harm

@en

P2093

Grace S Crowther

http://www.w3.org/2001/XMLSchema#string

P2860

The changing epidemiology of Clostridium difficile infections

The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing

Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation.

Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials.

Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome

Cycling empirical antibiotic therapy in hospitals: meta-analysis and models.

Treatment with monoclonal antibodies against Clostridium difficile toxins.

Fidaxomicin versus vancomycin for Clostridium difficile infection.

Burden of gastrointestinal disease in the United States: 2012 update.

Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections.

P304

333-337

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IDR.S87224

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mark H. Wilcox

P5530

4534091

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1009868054

http://www.w3.org/2001/XMLSchema#string

P698

26396535

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

P932

4576896

http://www.w3.org/2001/XMLSchema#string

P953

92557/